- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04145414
Cerebrospinal Fluid Movements Through Interventricular Foramina in Phase Contrast Magnetic Resonance Imaging (PC-MRI) (MLCSFIV)
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Besançon, France, 25000
- CHU de Besançon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Mini-Mental State Examination score > 28/30
Exclusion Criteria:
- MRI contraindication
- Medical or surgical history related to following pathologies: nervous system disease, cardiac arrhythmia, cardiac or respiratory insufficiency.
- Long-term medical treatment
- Ongoing pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cerebral magnetic resonance imaging x2
Cerebral MRI performed at enrolment visit and at +6 weeks (maximum)
|
Reproductibility test assessed with MRI for cerebrospinal fluid movements
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PC-MRI procedure reproductibility
Time Frame: week 6
|
Test-retest reproducibility of double measures (2nd measure at +48 hours minimum +6 weeks maximum) of 4 cerebrospinal liquid (CSL) flow parameters during PC-MRI. CSL flow through interventricular foramina will be measured within healthy volunteers, and 4 intraclass correlation coefficients (ICC) will be calculated. The test-retest coefficient will be considered satisfactory if > or = to 0.75 . |
week 6
|
Collaborators and Investigators
Investigators
- Principal Investigator: Laurent TATU, MD, PhD, CHU Besançon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- P/2019/425
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on CSF Circulation Disorder
-
Charles University, Czech RepublicRecruitingCSF Pressure Increased | CSF Leak | Puncture | CSF Circulation DisorderCzechia
-
Sahlgrenska University Hospital, SwedenCompletedRenal Function Disorder | Complication of Extracorporeal Circulation | Kidney Circulation DisorderSweden
-
University of FreiburgRecruitingIndication for CSF Dynamic Testing | Indication for CSF Infusion TestGermany
-
Oregon Health and Science UniversityNational Institutes of Health (NIH); National Center for Complementary and...Completed
-
Xinhua Hospital, Shanghai Jiao Tong University...UnknownBlood Circulation DisorderChina
-
Shanghai Chest HospitalUnknownNSCLC | SBRT | GM-CSFChina
-
University of ValenciaRecruitingBeta-amiloid and Phospho-tau Proteins in CSF | Ventricular Size After CSF Shunt | Cognitive Impairment and CSF Shunt | Motor Impairment Evolution After CSF ShuntSpain
-
First Affiliated Hospital of Zhejiang UniversityTongji Hospital; Ruijin Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsNot yet recruitingGranulocyte Colony-Stimulating Factor (G-CSF) MobilizationChina
-
Ceragem Clinical Inc.RecruitingBlood Circulation | Improving Blood CirculationSouth Korea
-
Oslo University HospitalEuropean CommissionWithdrawnIschemia | Carbon Dioxide | Blood Circulation Disorder | Biosensing TechniquesNorway
Clinical Trials on MRI
-
Cambridge University Hospitals NHS Foundation TrustRecruitingBreast CancerUnited Kingdom
-
Seoul National University Bundang HospitalBayerCompletedTraumaKorea, Republic of
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedOsteosarcoma | Ewing Sarcoma | Paget's DiseaseUnited States
-
University of EdinburghCompleted
-
Assistance Publique - Hôpitaux de ParisUnknownBrain Injury, Coma | Cardiac Arrest (CA) | Traumatic Brain Injury (TBI) | Aneurysmal Subarachnoid Hemorrhages (aSAH)France
-
Sheba Medical CenterUnknown
-
American College of Radiology Imaging NetworkNational Cancer Institute (NCI); Eastern Cooperative Oncology GroupUnknownBreast Cancer | BIRADS 3 | BIRADS 4 | BIRADS 5United States
-
Assistance Publique Hopitaux De MarseilleActive, not recruitingMultiple SclerosisFrance
-
Assistance Publique Hopitaux De MarseilleCompletedAmyotrophic Lateral SclerosisFrance
-
Centre Hospitalier Universitaire de Saint EtienneLohmann & RauscherRecruitingLow Back Pain | Healthy VolunteerFrance